JP3240600001
JP3240600001
KISSEI PHARMACEUTICAL CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 155.25B EUR | 199.38B EUR |
Enterprise Value | 103.49B EUR | 171.58B EUR |
Valuation Multiples | ||
Trailing P/E | 11.07x | -- |
Forward P/E | 16.85x | -- |
Price to Sales | 1.57x | -- |
Price to Book | 0.67x | 0.87x |
EV/Revenue | 1.05x | -- |
EV/EBITDA | 145.31x | -- |
Price to FCF (P/FCF) | -- | -- |
EV/FCF | -- | -- |
FCF Yield | -- | -- |